TrialBritish journal of cancer2012

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group.

Ø Fløtten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.